135 related articles for article (PubMed ID: 37966037)
21. Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study.
Araya T; Kita T; Ueda T; Terada N; Sakai T; Yamamura K; Kurokawa K; Uchida Y; Sone T; Kimura H; Kasahara K
Can Respir J; 2019; 2019():5315903. PubMed ID: 31015884
[TBL] [Abstract][Full Text] [Related]
22. Synchronous percutaneous core-needle biopsy and microwave ablation for stage I non-small cell lung cancer in patients with Idiopathic pulmonary fibrosis: initial experience.
Li B; Bie Z; Li Y; Guo R; Wang C; Li X
Int J Hyperthermia; 2023; 40(1):2270793. PubMed ID: 37848399
[TBL] [Abstract][Full Text] [Related]
23. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection.
Axtell AL; David EA; Block MI; Parsons N; Habib R; Muniappan A
Ann Thorac Surg; 2023 Sep; 116(3):533-541. PubMed ID: 37271447
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study.
Huang BY; Li XM; Song XY; Zhou JJ; Shao Z; Yu ZQ; Lin Y; Guo XY; Liu DJ; Li L
Int J Surg; 2018 May; 53():143-150. PubMed ID: 29555533
[TBL] [Abstract][Full Text] [Related]
25. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
26. A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Hanibuchi M; Kakiuchi S; Atagi S; Ogushi F; Shimizu E; Haku T; Toyoda Y; Azuma M; Kondo M; Kawano H; Otsuka K; Sakaguchi S; Nokihara H; Goto H; Nishioka Y
Lung Cancer; 2018 Nov; 125():93-99. PubMed ID: 30429044
[TBL] [Abstract][Full Text] [Related]
27. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
28. Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.
Tasaka Y; Honda T; Nishiyama N; Tsutsui T; Saito H; Watabe H; Shimaya K; Mochizuki A; Tsuyuki S; Kawahara T; Sakakibara R; Mitsumura T; Okamoto T; Kobayashi M; Chiaki T; Yamashita T; Tsukada Y; Taki R; Jin Y; Sakashita H; Natsume I; Saitou K; Miyashita Y; Miyazaki Y
Lung Cancer; 2021 May; 155():120-126. PubMed ID: 33798901
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia.
Hashimoto S; Iwata H; Hattori Y; Nakajima K; Nomura K; Hayashi K; Toshito T; Yamamori E; Akita K; Mizoe JE; Ogino H; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):56. PubMed ID: 35313905
[TBL] [Abstract][Full Text] [Related]
30. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.
Peng J; Bie Z; Li Y; Guo R; Li X
Eur Radiol; 2023 Dec; ():. PubMed ID: 38114848
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T
J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031
[TBL] [Abstract][Full Text] [Related]
33. Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease.
Kenmotsu H; Naito T; Mori K; Ko R; Ono A; Wakuda K; Imai H; Taira T; Murakami H; Endo M; Takahashi T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):521-6. PubMed ID: 25563718
[TBL] [Abstract][Full Text] [Related]
34. Computed Tomography-Guided Percutaneous Radiofrequency Ablation in Older Adults With Early-Stage Peripheral Lung Cancer: A Retrospective Cohort Study.
Lu Y; Lu C; Xu D; Huang F; He Z; Lei J; Sun H; Zeng J
Cancer Control; 2022; 29():10732748211070702. PubMed ID: 35076322
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease.
Choi MK; Hong JY; Chang W; Kim M; Kim S; Jung HA; Lee SJ; Park S; Chung MP; Sun JM; Park K; Ahn MJ; Ahn JS
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1217-25. PubMed ID: 24696125
[TBL] [Abstract][Full Text] [Related]
36. A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H; Uchibori K; Jin Y; Tsutsui T; Honda T; Sakakibara R; Mitsumura T; Nukui Y; Shirai T; Masuo M; Suhara K; Furusawa H; Yamashita T; Ohba T; Saito K; Takagiwa J; Miyashita Y; Inase N; Miyazaki Y
Thorac Cancer; 2022 May; 13(9):1267-1275. PubMed ID: 35322551
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Chan MV; Huo YR; Cao C; Ridley L
Eur Radiol; 2021 Jul; 31(7):5421-5433. PubMed ID: 33449192
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702).
Gobara H; Arai Y; Kobayashi T; Yamakado K; Inaba Y; Kodama Y; Yamagami T; Sone M; Watanabe H; Okumura Y; Shinya T; Kurihara H; Kanazawa S
Jpn J Radiol; 2016 Aug; 34(8):556-63. PubMed ID: 27260478
[TBL] [Abstract][Full Text] [Related]
39. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlook.
Acksteiner C; Steinke K
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):82-90. PubMed ID: 25335916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
